Androgenetic Alopecia: Case Study and Treatment Options

The review discusses traditional hair loss treatments like minoxidil and finasteride, and newer options like Low-Level Laser Therapy, microneedling, and platelet-rich plasma for androgenetic alopecia. It highlights the need for more high-quality trials to assess these treatments' effectiveness and standardized protocols for emerging therapies.

A 22-year-old has been using dutasteride, oral minoxidil, platelet-rich plasma therapy, and low-level laser therapy for hair loss but is still experiencing progression from Norwood 2 to 3. Others suggest increasing dutasteride dosage or trying additional treatments like RU58841 or topical finasteride.

The user is using a combination of finasteride, minoxidil, ketoconazole, pumpkin seeds, laser therapy, PRP, dermaroller, and vitamins for hair loss. They are advised to switch to oral finasteride and be patient, as results may take up to a year, with a hair transplant as a potential future option.

Various treatments like finasteride, minoxidil, dutasteride, and microneedling with PRP had no effect on hair loss. The user is considering laser diode caps as a potential option.

The user experienced chronic telogen effluvium and mild male pattern baldness, treated with finasteride, oral minoxidil, and later switched to dutasteride, which stopped excessive hair shedding. Other treatments like low-level laser therapy, hair loss shampoos (except ketoconazole), and supplements were ineffective.

The user is considering using topical finasteride for hairline recession and thinning, despite having low DHT levels and previous side effects from oral finasteride. They are also taking 2.5 mg of oral minoxidil, which has not resulted in regrowth or stabilization.